GANX vs ZBRA · $53.0M cap vs P/E 28, rev $3.05B
Gain Therapeutics Inc (GANX) versus Zebra Technologies Corporation (ZBRA) — a side-by-side from cached financials, not a winner call.
Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.
Zebra Technologies Corporation (ZBRA) is a communication equipment company listed on NASDAQ.
GANX does not have a complete income-statement cache yet.
Latest reported ZBRA revenue for 2026-07-04 was $3.05B. Net income was $368.0M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
GANX currently screens at market cap $53.0M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
Not investment advice. Open the GANX and ZBRA stock pages for the full models.
Not investment advice.